Biomarker-driven medical research involving adults who have or are at risk of developing cancer
1400+ member research sites
- Tweets 9,498
- Following 2,487
- Followers 6,624
- Likes 3,807
#FindingsFriday: New research from 9 @eaonc trials found most patients who smoked before their #cancer diagnosis kept smoking—during and after treatment. #SmokingCessation support needs to be built into cancer care, not left to chance. More in @JCOOP_ASCO: bit.ly/4dvJZxj
215
Do you have #AcuteMyeloidLeukemia (#AML) and are age 60 or older? If so, you may be able to participate in this study of a potential new treatment. Learn more: bit.ly/mm1oa-ea02-study #leukemia #leusm
222
Do you have newly diagnosed #Glioblastoma? If so, you may be able to participate in this study of a new treatment approach. Learn more about EAF223/GABLE here: bit.ly/gable-trial
219
ECOG-ACRIN Cancer Research Group retweeted
Happy World Cancer Research Day! I'm grateful that I began my NET journey in a clinical trial (@NovartisCT NETTER-2), and now add to @eaonc's efforts as a patient advocate. Everything starts with a question - thank you all for asking them, over and over, for patients' sake. 🦓
1
1
135
ICYMI, more than a decade after TAILORx changed #BreastCancer care, its biorepository is yielding new insights: researchers used #AI to review archived pathology slides from 4,000+ trial participants, developing a more accurate recurrence-risk model. More: bit.ly/4cY42EB
1
232
On #WorldCancerResearchDay, we honor those at the center of discovery: patients in clinical trials, investigators who design them, & research teams worldwide. ECOG-ACRIN turns collaborations into better prevention, detection & treatment. #AdvancingCancerResearchTogether @IARCWHO
2
228
#ClinicalTrial EAA181/EQUATE, led by @myelomaMD of @mayoclinic, is testing the use of combination therapy in adult patients with newly diagnosed #MultipleMyeloma. For more information: bit.ly/eaa181equate #MMSM #NDMM
209
EA8231 is a phase 3 study comparing pembrolizumab & sacituzumab govitecan versus standard chemotherapy in patients with advanced #UrothelialCancer. The trial aims to improve treatment options & guide further research. ➡️ bit.ly/ea8231-study
1
215
Clinical study EA3191 is testing a new treatment approach for patients with squamous cell carcinoma of the head and neck (#HNSCC) that has come back after initial therapy. Learn more: bit.ly/ea3191-study #HeadAndNeckCancer #HNCA
1
235
Do you have early-stage #melanoma and are age 75 or older? If so, you may be eligible to participate in this study of a potential new treatment approach. More info: bit.ly/ea6244-study #SkinCancer #MelanomaResearch
214
Do you have advanced #cancer that has become worse following treatment, or advanced cancer for which no standard treatment exists? If so, you may be able to join the #ComboMATCH #PrecisionMedicine study. Learn more: bit.ly/ComboMATCH
221
Clinical trial EAA232, led by @MMBaljevicMD of @VUMC_Cancer is a randomized phase 2 trial for patients with high-risk multiple myeloma that has returned or is not responding after treatment. Learn more: bit.ly/eaa232-study cc: @VincentRK, @myelomaMD, @theMMRF, @IMFmyeloma
219
Decades of federal investment in #CancerResearch have saved millions of lives. @AACR's new Cancer Progress Report asks Congress to sustain NIH/NCI funding & protect grants from interference—because progress against #cancer depends on it. More: bit.ly/4xC3bRk
1
227
Urothelial cancer is the most common type of #bladdercancer. The EA8192 study is evaluating durvalumab and chemotherapy for patients with high grade upper tract urothelial cancer prior to nephroureterectomy. bit.ly/ea8192-trial cc: @BladderCancerUS @JCensits @PGrivasMDPhD
2
871
Do you have #BreastCancer that was recently removed by surgery? If so, you may be eligible for #ClinicalTrial EA1242/RxFINE-Low, a study exploring potential new treatment approaches. More info: bit.ly/ea1242-study cc: @NBCF, @SusanGKomen, @BCRFcure
220
Do you have advanced non-small cell #LungCancer and are age 70 or older? If so, you may be able to participate in this study of a new treatment approach. Learn more: bit.ly/ea5221-achieve
1
210
Do you have #GastricCancer that has spread to the abdominal cavity? If so, you may be eligible to participate in this study of a potential new treatment approach. Learn more: bit.ly/ea2234-stopgap-ii #stomachcancer #cancerawareness
4
841
Can patients with high-risk retroperitoneal #sarcoma benefit from neoadjuvant chemotherapy? The international EA7211/STRASS 2 #ClinicalTrial, led in the US by @kencardonaMD, aims to find out. More: bit.ly/EA7211 #leiomyosarcoma #liposarcoma Cc: @EORTC @richardriedelmd
1
1
245
Why does #BreastCancer come back after treatment? The EA1241 #ClinicalTrial, led by @jsparano, aims to find out by evaluating tissue samples from patients who previously enrolled in TAILORx & RxPONDER. More: bit.ly/EA1241 cc: @KalinskyKevin, @RimapatelMD
224
The MM1OA-EA02 clinical study is testing a new treatment approach for patients with #AcuteMyeloidLeukemia who are age 60 or older. Learn more: bit.ly/mm1oa-ea02-study #AML #leukemia
223